List of insiders holdings for Cartesian Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Brunn Carsten President and CEO | 2024-01-04 17:07:39 | 10,887,056 0 | 10,887,056 | Form 4 |
| TAS Partners LLC Leukon Investments LP SPRINGER TIMOTHY A Director | 2024-11-18 21:44:37 | 9,481,816 0 | 9,481,816 | Form 13D |
| SPRINGER TIMOTHY A Director 10% Owner | 2024-11-18 21:44:37 | 9,481,816 0 | 9,481,816 | Form 13D |
| Davis Blaine Chief Financial Officer | 2024-01-04 17:08:29 | 5,534,000 0 | 5,534,000 | Form 4 |
| Hoge Elizabeth Seven One Eight Three Four Irrevocable Trust 10% Owner | 2024-10-15 16:43:23 | 0 5,118,039 | 5,118,039 | Form 4 |
| Kalayoglu Murat Director 10% Owner | 2024-10-15 16:53:32 | 506,377 4,611,662 | 5,118,039 | Form 4 |
| Polaris Venture Management Co. V L.L.C. Polaris Venture Partners V L.P. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Special Founders' Fund V L.P. 10% Owner | 2020-02-12 16:42:33 | 2,789,889 0 | 2,789,889 | Form 13D |
| ORBIMED ADVISORS LLC OrbiMed Capital GP III LLC ISALY SAMUEL D Director 10% Owner | 2020-02-05 16:36:54 | 2,779,064 0 | 2,779,064 | Form 13D |
| GORDON CARL L Director 10% Owner | 2016-06-29 16:49:20 | 0 1,825,415 | 1,825,415 | Form 4 |
| Flagship Ventures Fund 2007 L.P. Flagship Ventures 2007 General Partner LLC AFEYAN NOUBAR 10% Owner | 2016-06-29 16:44:05 | 0 1,651,862 | 1,651,862 | Form 4 |
| RUSNANO 10% Owner | 2018-02-06 15:57:02 | 1,118,368 0 | 1,118,368 | Form 13G |
| Nanodimension Management Ltd Nanodimension Limited Partnership 10% Owner | 2018-02-14 15:59:06 | 1,085,164 0 | 1,085,164 | Form 13G |
| Osage University Partners II L.P. Osage University GP II L.P. Osage Partners LLC 10% Owner | 2016-06-29 16:47:05 | 0 862,543 | 862,543 | Form 4 |
| Singer Michael Director | 2024-11-21 18:51:39 | 90,933 654,868 | 745,801 | Form 4 |
| COX CARRIE SMITH Director | 2024-01-04 17:05:15 | 638,881 0 | 638,881 | Form 4 |
| von Andrian Ulrich 10% Owner | 2016-06-21 18:22:23 | 513,944 100,642 | 614,586 | Form 3 |
| KANIA EDWIN M JR Director | 2017-05-16 17:28:58 | 26,528 560,067 | 586,595 | Form 4 |
| LANGER ROBERT 10% Owner | 2016-06-21 18:30:23 | 556,695 0 | 556,695 | Form 3 |
| ZENNER PATRICK J Director | 2024-01-04 17:04:47 | 461,248 0 | 461,248 | Form 4 |
| TRABER PETER G Chief Medical Officer | 2023-09-26 18:00:28 | 451,826 0 | 451,826 | Form 4 |
| Tan Kevin Chief Financial Officer | 2022-01-05 16:36:06 | 417,000 0 | 417,000 | Form 4 |
| Farokhzad Omid Director | 2019-08-16 16:16:57 | 188,004 227,677 | 415,681 | Form 4/A |
| DeSilva Nishan M Director | 2024-01-04 17:05:35 | 413,000 0 | 413,000 | Form 4 |
| Sallin Aymeric Director | 2024-01-04 17:07:20 | 406,000 0 | 406,000 | Form 4 |
| CAUTREELS WERNER President and CEO | 2017-11-14 21:57:55 | 321,203 0 | 321,203 | Form 4 |
| Dahms Bradford D. Chief Financial Officer | 2021-01-06 16:49:34 | 268,000 0 | 268,000 | Form 4 |
| Johnston Lloyd P. Chief Operations Officer | 2023-01-06 17:16:11 | 265,515 0 | 265,515 | Form 4 |
| Kishimoto Takashi Kei Chief Scientific Officer | 2023-06-01 16:27:18 | 225,316 0 | 225,316 | Form 4 |
| Kurtoglu Metin Chief Technology Officer | 2024-12-11 16:28:35 | 212,132 0 | 212,132 | Form 4 |
| VTB Capital I2BF Netherlands B.V. Selecta RKFN Ltd. 10% Owner | 2016-06-29 16:47:35 | 0 178,890 | 178,890 | Form 4 |
| Kogan Elona Esq. General Counsel | 2020-01-06 20:08:14 | 140,000 0 | 140,000 | Form 4 |
| Donohue Ann K. VP Finance | 2021-06-03 16:31:48 | 135,645 0 | 135,645 | Form 3 |
| Jewell Christopher M Chief Scientific Officer | 2024-11-21 18:50:12 | 116,372 0 | 116,372 | Form 4 |
| English Emily SVP, Head of Manufacturing | 2024-04-19 16:49:33 | 112,979 0 | 112,979 | Form 3 |
| Smolinski Stephen Chief Commercial Officer | 2020-01-06 20:08:56 | 100,000 0 | 100,000 | Form 4 |
| Schecter Alison D. Chief Medical Officer | 2020-01-06 20:08:37 | 100,000 0 | 100,000 | Form 4 |
| Miljkovic Milos Chief Medical Officer | 2024-11-18 19:28:04 | 99,329 0 | 99,329 | Form 4 |
| ANDO GORAN Director | 2023-01-04 17:04:42 | 75,000 0 | 75,000 | Form 4 |
| Leaman John Harold CFO, Treas. & Hd Corp Strategy | 2018-06-19 19:05:26 | 50,000 0 | 50,000 | Form 4 |
| Keller Peter Chief Business Officer | 2017-07-11 16:43:50 | 32,000 0 | 32,000 | Form 4 |
| BARABE TIMOTHY C Director | 2024-08-14 16:41:54 | 29,366 0 | 29,366 | Form 4 |
| Abraham David GC, CCO & Corporate Secretary | 2018-06-19 19:06:25 | 25,000 0 | 25,000 | Form 4 |
| Malik Kemal Director | 2024-07-03 16:10:20 | 13,533 0 | 13,533 | Form 4 |
| Nashat Amir Director | 2019-06-18 16:21:42 | 10,000 0 | 10,000 | Form 4 |
| HUTT PETER BARTON Director | 2018-06-19 19:03:52 | 10,000 0 | 10,000 | Form 4 |
| Sands Earl Chief Medical Officer | 2017-11-21 16:08:37 | 7,500 0 | 7,500 | Form 4 |
| Siewers David CFO and Treasurer | 2017-09-22 17:30:29 | 5,000 0 | 5,000 | Form 4 |
| Myers Scott Dunseth Director | 2023-11-15 17:16:10 | 0 0 | 0 | Form 4 |
| Shaydullina Leysan Director | 2016-06-21 18:29:24 | 0 0 | 0 | Form 3 |